Table 2.
Clinical Features | Mean (SD)/Median [IQR]/N (%) |
---|---|
Number of defining categories per patient | 2.5 (0.8) |
Patients with ≥ 3 categories | 175 (39.5%) |
Prevalence of defining categories in recruited polypathological patients | |
Category A (heart diseases) | 374 (84.6%) |
Category B (kidney/autoimmune diseases) | 202 (45.7%) |
Category C (lung diseases) | 183 (41.4%) |
Category E (neurological diseases) | 133 (30.1%) |
Category F (peripheral arterial disease/diabetes with neuropathy) | 80 (18.1%) |
Category G (chronic neoplasia/anemia) | 70 (15.8%), |
Category H (degenerative osteoarticular disease) | 43 (9.7%) |
Category D (liver disease) | 28 (6.3%) |
Number of other comorbidities per patient | 5.9 (2.3) |
Cardiovascular | 1.8 (0.9) |
Endocrine and metabolic | 1.6 (1) |
Respiratory | 0.75 (0.9) |
Most frequent comorbidities | |
Hypertension | 380 (86%) |
Dyslipemia | 232 (52.5%) |
Diabetes with no visceral involvement | 216 (49%) |
Atrial fibrillation | 178 (40%) |
Obesity | 159 (36%) |
Anxiety and depressive disorders | 74 (17%) |
Benign prostate hyperplasia | 64 (14.5%) |
Osteoporosis | 42 (9.5%) |
Frequent symptoms | |
Fatigue | 304 (70%) |
Anorexia | 212 (48%) |
Insomnia | 194 (44%) |
Chronic pain | 178 (40%) |
Cough | 158 (36%) |
Patients with basal III-IV class of NYHA // III-IV class of mMRC | 128 (29%) |
Patients with delirium in last hospital admission | 76 (17%) |
Nausea/Vomiting | 37 (8.5%) |
Pressure ulcer(s) | 35 (8%) |
PROFUND index | 6 [6] |
Number of prescribed drugs at inclusion / Patients with polypharmacy | 10 (4)/429 (96.5%) |
Patients with home oxygen therapy | 74 (17%) |
Hospitalizations in last 3 months / total days in hospital in last 3 months | 0.6 (0.8)/5 (9) |
Basal Barthel´s Index | 66 (30) |
SD: standard deviation; IQR: interquartile range; NYHA: New York Heart Association; mMRC: Medical Research Council.